1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E2E8FB7FD4DB5E7C8525815A0067F809
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-usa-based-field-medical-team-interactions-with-managed-care-customers-team-activities-and-staffing?opendocument
18
19opendocument
203.239.87.20
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Field Medical Excellence

U.S.-Based Field Medical Team Interactions with Managed Care Customers: Team Activities and Staffing

ID: 5467


Features:

10 Info Graphics

19 Data Graphics

350+ Metrics

2 Narratives


Pages/Slides: 37


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "U.S.-Based Field Medical Team Interactions with Managed Care Customers: Team Activities and Staffing"

STUDY OVERVIEW


Field medical teams have become one of the principal ways that pharmaceutical companies interact with managed care customers. Field medical team functions that serve managed care organizations include Health Outcomes Liaisons (HOLs), Managed Care Liaisons (MCLs) and others, including MSLs.

But there is significant variance across pharma companies using these roles to interact with payers in not only which field medical activities take up the most time and are deemed most important but also the level of staffing across the different field roles.

This study provides benchmarks around the amount of time internal and external activities take up for field staff that serve payers and which activities are seen as most valuable. In addition, the study presents staffing benchmarks across key U.S.-based field medical functions.

This study includes a Top 10 Pharma segment that includes 8 companies that are among the Top 10 pharma by 2016 revenues.

KEY TOPICS


Field Medical Team Activities

  • Time Spent on Key External and Internal Responsibilities
  • Value of Key External and Internal Responsibilities

Field Medical Team Staffing
  • Staffing Levels for FMT roles
  • Reporting Lines for FMT

KEY METRICS

  • What is the overall percentage of time spent on external (account) and internal (corporate) responsibilities for the principal field medical role that serves managed care customers?
  • What is the percentage of time spent on the listed external activities for the principal field medical role that serves managed care customers?
  • What is the percentage of time spent on the listed internal activities for the principal field medical role that serves managed care customers?
  • Indicate the value you associate with the listed internal activities for the principal field medical role that serves managed care customers?
  • Indicate the value you associate with the listed external activities for the principal field medical role that serves managed care customers?
  • Indicate the number of in-line and pipeline products supported by the principal field medical role that serves managed care customers?
  • Indicate the number of field medical team US-based FTEs you have for each role listed
  • What is the ratio of manager to the principal field role serving managed care customers?

SAMPLE KEY FINDING

  • Activity Importance Rating: Providing payers with clinical updates on marketed products is seen as a highly valued activity by 71% of participants. This activity also consumes the most time - 24% on average – of HOLs, MCLs, and Hybrid. Meanwhile, pre-meeting preparation for customer engagement was rated as the most valued internal activity for these roles by 71% of participants, although only 5% of their time is spent on that activity.

METHODOLOGY

Best Practices, LLC engaged 17 leaders from 16 leading biopharmaceutical companies through a benchmarking survey instrument and interviews.


Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Biopharmaceutical; Clinical Research; Laboratories; Chemical


Companies Profiled:
Bayer; Foundation Medicine; Abbvie; Janssen; GlaxoSmithKline ; Sanofi; Novartis; Merck; Pfizer; Sunovion; Boehringer Ingelheim; Teva Pharmaceutical Industries Ltd; Takeda Pharmaceuticals; Shire; Biogen; Celgene

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.